Allogene Therapeutics (ALLO) Institutional Ownership $1.60 -0.08 (-4.76%) Closing price 04:00 PM EasternExtended Trading$1.63 +0.03 (+1.87%) As of 07:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Allogene Therapeutics (NASDAQ:ALLO)CurrentInstitutional OwnershipPercentage83.63%Number ofInstitutional Buyers(last 12 months)74TotalInstitutional Inflows(last 12 months)$68.07MNumber ofInstitutional Sellers(last 12 months)35TotalInstitutional Outflows(last 12 months)$20.21M Get ALLO Insider Trade Alerts Want to know when executives and insiders are buying or selling Allogene Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ALLO Institutional Buying and Selling by Quarter Remove Ads Allogene Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails3/18/2025 California State Teachers Retirement System135,554$289K0.0%+6.0%0.065% 2/18/2025 Navalign LLC59,865$128K0.0%-20.6%0.029% 2/17/2025 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC270,559$576K0.0%+18.2%0.129% 2/17/2025 Squarepoint Ops LLC20,345$43K0.0%-89.2%0.010% 2/17/2025 Two Sigma Advisers LP2,702,200$5.76M0.0%+12.1%1.289% 2/17/2025 Two Sigma Investments LP2,712,139$5.78M0.0%-3.1%1.294% 2/17/2025 Tidal Investments LLC135,952$290K0.0%-4.8%0.065% 2/17/2025 Rafferty Asset Management LLC367,445$783K0.0%+15.9%0.175% 2/17/2025 Raiffeisen Bank International AG430,000$903K0.0%N/A0.205% 2/17/2025 ProShare Advisors LLC46,082$98K0.0%+25.6%0.022% Get the Latest News and Ratings for ALLO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Allogene Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/17/2025 Patient Square Capital LP1,489,909$3.17M1.2%N/A0.711% 2/17/2025 Nuveen Asset Management LLC300,871$641K0.0%+18.3%0.143% 2/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.305,895$651K0.0%+23.6%0.146% 2/17/2025 Graham Capital Management L.P.41,737$89K0.0%N/A0.020% 2/17/2025 Coastal Bridge Advisors LLC221,059$471K0.1%-45.5%0.105% 2/17/2025 D. E. Shaw & Co. Inc.54,517$116K0.0%-39.6%0.026% 2/17/2025 DAFNA Capital Management LLC1,240,118$2.64M0.7%+18.1%0.591% 2/17/2025 Caption Management LLC15,000$32K0.0%N/A0.007% 2/17/2025 Brevan Howard Capital Management LP87,573$187K0.0%+38.9%0.042% 2/17/2025 Caxton Associates LP206,380$440K0.0%-14.8%0.098% 2/17/2025 Bank of America Corp DE1,163,743$2.48M0.0%+99.3%0.555% 2/17/2025 BNP Paribas Financial Markets849,658$1.81M0.0%+1,732.2%0.405% 2/17/2025 Ameriprise Financial Inc.201,943$430K0.0%+14.0%0.096% 2/14/2025 Jane Street Group LLC164,523$350K0.0%-63.5%0.078% 2/14/2025 Foresite Capital Management VI LLC3,448,275$7.35M3.3%N/A1.645% 2/14/2025 Northern Trust Corp1,305,232$2.78M0.0%+4.5%0.623% 2/14/2025 Lynx1 Capital Management LP10,874,723$23.16M8.7%+75.3%5.187% 2/14/2025 Susquehanna Fundamental Investments LLC376,661$802K0.0%N/A0.180% 2/14/2025 Syon Capital LLC18,351$39K0.0%N/A0.009% 2/14/2025 Price T Rowe Associates Inc. MD4,485,572$9.56M0.0%-7.3%2.139% 2/14/2025 Hsbc Holdings PLC69,155$147K0.0%+32.0%0.033% 2/14/2025 MetLife Investment Management LLC38,020$81K0.0%-28.5%0.018% 2/14/2025 Dimensional Fund Advisors LP3,561,626$7.59M0.0%+30.4%1.699% 2/14/2025 Gilead Sciences Inc.1,156,689$2.46M0.2%N/A0.552% 2/13/2025 Zacks Investment Management480,874$1.02M0.0%-6.9%0.229% 2/13/2025 XTX Topco Ltd158,537$338K0.0%N/A0.076% 2/13/2025 Barclays PLC761,286$1.62M0.0%+122.0%0.363% 2/13/2025 Renaissance Technologies LLC554,541$1.18M0.0%-13.6%0.264% 2/13/2025 Legal & General Group Plc112,235$239K0.0%-11.9%0.054% 2/13/2025 Invesco Ltd.127,486$272K0.0%+7.0%0.061% Has Trump finally met his match? (Ad)Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance to walk away with gains as high as 235%, 459%, and 700% - all while the stock market got cut in half. Could he be right again?Click here for his emergency broadcast...2/13/2025 Cerity Partners LLC387,387$832K0.0%-10.4%0.185% 2/13/2025 Wells Fargo & Company MN104,593$223K0.0%+29.4%0.050% 2/12/2025 PAX Financial Group LLC12,832$27K0.0%N/A0.006% 2/12/2025 RPO LLC14,787$31K0.0%N/A0.007% 2/12/2025 JPMorgan Chase & Co.3,736,132$7.96M0.0%-8.6%1.782% 2/12/2025 Mitsubishi UFJ Asset Management Co. Ltd.253,576$548K0.0%+7.1%0.121% 2/11/2025 Vanguard Group Inc.8,000,692$17.04M0.0%-3.9%3.816% 2/11/2025 KLP Kapitalforvaltning AS20,400$43K0.0%N/A0.010% 2/11/2025 Sei Investments Co.48,320$103K0.0%N/A0.023% 2/11/2025 American Century Companies Inc.232,356$495K0.0%+16.5%0.111% 2/11/2025 Teacher Retirement System of Texas43,877$93K0.0%+28.9%0.021% 2/11/2025 Intech Investment Management LLC71,323$152K0.0%+72.6%0.034% 2/10/2025 Primecap Management Co. CA4,927,340$10.50M0.0%-13.1%2.350% 2/10/2025 Cibc World Markets Corp12,013$26K0.0%N/A0.006% 2/10/2025 Swiss National Bank287,900$613K0.0%+8.7%0.137% 2/7/2025 HighTower Advisors LLC12,150$26K0.0%-59.0%0.006% 2/6/2025 Charles Schwab Investment Management Inc.1,188,838$2.53M0.0%+0.8%0.567% 2/4/2025 Bank of New York Mellon Corp330,769$705K0.0%+4.1%0.158% 1/31/2025 Partners Capital Investment Group LLP93,248$199K0.0%-63.4%0.044% 1/30/2025 Rhumbline Advisers191,714$408K0.0%+10.1%0.091% 1/30/2025 Vontobel Holding Ltd.195,457$416K0.0%+788.4%0.093% 1/24/2025 abrdn plc364,382$776K0.0%N/A0.174% 1/17/2025 Bourgeon Capital Management LLC118,700$253K0.0%-16.7%0.057% 1/6/2025 Nordea Investment Management AB460,641$986K0.0%+2.1%0.220% 12/26/2024 JPMorgan Chase & Co.4,087,506$11.45M0.0%-0.9%1.949% 11/25/2024 Tidal Investments LLC142,747$400K0.0%-39.7%0.068% 11/19/2024 Barclays PLC342,973$959K0.0%+101.5%0.164% 11/16/2024 Geode Capital Management LLC3,227,104$9.04M0.0%+14.4%1.539% 11/15/2024 Barclays PLC342,973$959K0.0%+101.5%0.164% 11/15/2024 MML Investors Services LLC20,000$56K0.0%N/A0.010% 11/15/2024 Zacks Investment Management516,601$1.45M0.0%N/A0.246% 11/15/2024 EP Wealth Advisors LLC24,475$69K0.0%+125.6%0.012% 11/15/2024 State Street Corp7,013,083$19.64M0.0%-8.5%3.345% 11/15/2024 Erste Asset Management GmbH31,400$91K0.0%N/A0.015% 11/14/2024 Vestal Point Capital LP1,500,000$4.20M0.3%-31.8%0.715% 11/14/2024 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC228,806$641K0.0%-14.2%0.109% 11/14/2024 MetLife Investment Management LLC53,147$149K0.0%-10.1%0.025% 11/13/2024 BNP Paribas Financial Markets46,374$130K0.0%+541.5%0.022% 11/13/2024 FMR LLC30,026,956$84.08M0.0%-3.9%14.321% 11/13/2024 The Manufacturers Life Insurance Company486,023$1.36M0.0%+1.2%0.232% 11/9/2024 Intech Investment Management LLC41,331$116K0.0%N/A0.020% 11/6/2024 Cornercap Investment Counsel Inc.28,533$80K0.0%-55.0%0.014% 11/6/2024 Curi RMB Capital LLC149,577$419K0.0%+47.5%0.072% 10/25/2024 China Universal Asset Management Co. Ltd.40,219$113K0.0%+64.0%0.019% 10/22/2024 Private Advisor Group LLC12,087$34K0.0%N/A0.006% 10/11/2024 Creative Planning61,396$172K0.0%+108.7%0.029% 10/10/2024 Exchange Traded Concepts LLC60,675$170K0.0%+25.5%0.029% 10/3/2024 SG Americas Securities LLC46,967$132K0.0%+252.7%0.022% 8/16/2024 Perceptive Advisors LLC2,725,000$6.35M0.2%N/A1.304% 8/16/2024 Algert Global LLC14,808$35K0.0%N/A0.007% A market crash is coming—here’s when (Ad)The stock market cycle I've used to identify the most likely day of the next market crash is the exact same indicator that helped me call the bear market of 2018... the bull market in 2020... the bear market in 2022... the roaring bull markets in 2023 and 2024... and more. I'm convinced it has helped me identify the next big crash too. We are at an important juncture in the markets. Knowing what to do in the months to come is critical.Click here to check out my full write-up.8/15/2024 Susquehanna Fundamental Investments LLC418,699$976K0.0%+46.2%0.200% 8/15/2024 Lynx1 Capital Management LP2,228,295$5.19M1.9%N/A1.066% 8/15/2024 The Manufacturers Life Insurance Company480,381$1.12M0.0%+70.3%0.230% 8/15/2024 AQR Capital Management LLC27,287$64K0.0%N/A0.013% 8/15/2024 Caxton Associates LP466,110$1.09M0.0%+8.1%0.223% 8/14/2024 Squarepoint Ops LLC126,628$295K0.0%N/A0.061% 8/14/2024 Profund Advisors LLC76,160$177K0.0%-37.1%0.036% 8/12/2024 Hsbc Holdings PLC44,664$103K0.0%-17.5%0.021% 8/12/2024 E Fund Management Co. Ltd.25,333$59K0.0%-31.8%0.012% 8/9/2024 Primecap Management Co. CA5,670,226$13.21M0.0%+4.1%2.713% (Data available from 1/1/2016 forward)Remove Ads ALLO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ALLO shares? During the previous two years, 135 institutional investors and hedge funds held shares of Allogene Therapeutics. The most heavily invested institutionals were FMR LLC ($84.08M), Lynx1 Capital Management LP ($23.16M), State Street Corp ($19.64M), Vanguard Group Inc. ($17.04M), Primecap Management Co. CA ($10.50M), Price T Rowe Associates Inc. MD ($9.56M), and Geode Capital Management LLC ($9.04M).Learn more on ALLO's institutional investors. What percentage of Allogene Therapeutics stock is owned by institutional investors? 83.63% of Allogene Therapeutics stock is owned by institutional investors. Learn more on ALLO's institutional investor holdings. Which institutional investors have been buying Allogene Therapeutics stock? Of the 116 institutional investors that purchased Allogene Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Lynx1 Capital Management LP ($6.90M), Foresite Capital Management VI LLC ($3.45M), Vanguard Group Inc. ($3.09M), Perceptive Advisors LLC ($2.73M), Price T Rowe Associates Inc. MD ($1.81M), Baker BROS. Advisors LP ($1.58M), and Patient Square Capital LP ($1.49M). How much institutional buying is happening at Allogene Therapeutics? Institutional investors have bought a total of 39,600,949 shares in the last 24 months. This purchase volume represents approximately $113.90M in transactions. Which Allogene Therapeutics major shareholders have been selling company stock? Of the 48 institutional investors that sold Allogene Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: FMR LLC ($1.23M), Vanguard Group Inc. ($1.15M), Primecap Management Co. CA ($1.10M), ExodusPoint Capital Management LP ($730.95K), Vestal Point Capital LP ($700K), State Street Corp ($655.04K), and BNP Paribas Financial Markets ($510.14K). How much institutional selling is happening at Allogene Therapeutics? Institutional investors have sold a total of 9,446,520 shares in the last 24 months. This volume of shares sold represents approximately $29.34M in transactions. Related Companies IMCR Institutional Ownership ANIP Institutional Ownership DYN Institutional Ownership INDV Institutional Ownership AMPH Institutional Ownership ARDX Institutional Ownership EVO Institutional Ownership ETNB Institutional Ownership OCUL Institutional Ownership GPCR Institutional Ownership This page (NASDAQ:ALLO) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allogene Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Allogene Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ALLO Stock Free ALLO Stock Alerts